OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/22/2025
Back to search
Official data from USPTO
PHARMAGEND
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079397084Class
1, 5, 35, 40, 42
Filing
79397084
Registration
7717933
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 5, 35, 40, 42
Filing date
03/18/2024
Registration date
03/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/11/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
24
Owner location
SG
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PharmaGend Global Medical Services Pte Ltd
Representatives
Esther Kim
Technical classification
Nice Classes
Class 1Class 5Class 35Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Bases being chemical preparations of pharmaceutical drug product formulationmanufacturingpackingtesting and release to market; salts being chemical preparations for improved therapeutic actionsadditional indicationdrug product stability enhancement and bioavailability improvement in pharmaceutical products; cellulose derivatives being chemical preparations for use as excipients in drug formulationproviding controlled release and delayed release of drug enhancing bioavailability of drug product; chemical preparations for scientific purposesother than for medical or veterinary use; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; animal extracts in the nature of from bovine source for use in pharmaceutical and nutraceutical manufacturingparticularly in dietary supplements and therapeutic drug products as well as nutritional products for the food industry; biological preparations for use in industry and scienceother than for medical or veterinary purposes; diagnostic preparationsother than for medical or veterinary purposes; plant extractsother than essential oilsfor use in the manufacture of pharmaceuticals; plant extractsother than essential oilsfor use in the manufacture of cosmetics
Class 5
Immunological products for intravenous injectionsnamely for immune system supportsuch as vaccinesmonoclonal antibodies (mAbs)Cytokines/Cytokine Inhibitors; tablets for medicines specifically diureticanti-fungaldigestive disordersanti-inflammatoryantidiabeticdementia tablets for treating common infections and chronic diseases; drinking water fused with electrolytessaltsHemodialysis solutionsuitable for rehydration and maintenance therapy for medical purposes; medicinal ointments for treating skin conditionssuch as dermatitiswoundsburnsoffering antiseptic and healing properties; gelatin capsules sold empty for pharmaceuticals; slimming pills; medicines for human purposes for treating various ailments ranging from cough and cold medicines to cardiac disease; nutraceutical preparations for therapeutic or medical purposes for treating digestive disordersvitamin deficiencytherapeutic dosage of vitamins; biochemical medicines for treating metabolic disordershormonal imbalancesautoimmune diseasesrare genetic conditionssuch as enzyme replacement therapiespeptide-based drugsnucleotide-based therapies; pharmaceutical preparations for treating heart diseasesasthmaobesitydiabeteshypertension
Class 35
Import-export agency services; business management consultancy; outsourcing services; business research; wholesale store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; retail store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies
Class 40
Custom assembling of materials for othersmulti-layer coated tabletsliquid filled hard gelatin capsulesbottle filling activities; providing information relating to material treatment; processing of metal surfaces using precision grinding techniques; irradiation of food; cryopreservation services; food and drink processing for others; processing of chemicals; sorting of waste and recyclable material; bookbinding; grinding
Class 42
Technological research in the field of formulation developmentscale-up batchesformulation refinementdrug delivery systemsoptimization of production processes; conducting technical project studiesbioequivalence studiesclinical trial study design and regulatory compliance research in the pharmaceutical field; scientific laboratory services; providing scientific informationadvice and consultancy relating to carbon offsetting; quality control for others; industrial inspection serialization of productsmedical devices; quality assessment of pharmaceutical manufacturing processesprocess validationfocusing on batch consistencycontamination controlimpurity profiling and GMP compliance; biological research; medical and scientific researchconducting clinical trials for others; medical research
Publications
History of USPTO decisions and trademark events.
26 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/05/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/05/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/18/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/25/2025
FIMP
FINAL DISPOSITION PROCESSED
09/24/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/12/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/11/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/21/2025
PUBO
PUBLISHED FOR OPPOSITION
01/21/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/15/2025
ISCR
WITHDRAWN FROM ISSUE - OG REVIEW QUERY
01/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/27/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/22/2024
RFNT
REFUSAL PROCESSED BY IB
10/19/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/02/2024
RFRR
REFUSAL PROCESSED BY MPU
10/02/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/27/2024
CNRT
NON-FINAL ACTION WRITTEN
09/26/2024
DOCK
ASSIGNED TO EXAMINER
09/25/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/10/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/06/2024
Continuous trademark protection
Get notified about every new filing that threatens PHARMAGEND or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.